semaglutide aging A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Pilot study of epigenetic aging

Novo Nordisk says its trial of Rybelsus included 9,650 patients who were randomized to receive either Rybelsus 14 mg or the placebo daily

How GLP-1 medication may reduce alcohol cravings GLP-1 medications, such as semaglutide, commonly known by brand names like Ozempic and Wegovy, work by mimicking a hormone that regulates appetite and blood sugar levels

While this might seem cheaper, its also risky: No physician monitoring means no dosage adjustments or safety oversight No nutritional guidance means less optimal results No accountability means higher dropout rates Youre on your own if you experience side effects or complications The difference between $250/month DIY and $275-$333/month for comprehensive physician-supervised care is minimaland the outcomes are vastly different

Many people who take GLP-1 drugs to treat obesity or diabetes discontinue them

Monitoring Symptoms Keep a detailed record of your symptoms, including their frequency and severity

Cardio provides cardiovascular health benefits and additional calorie burn that semaglutide doesn't replicate